Impact of the Penicillium chrysogenum genome on industrial production of metabolites


DOI: 10.1007/s00253-011-3476-z

Cite this article as:
van den Berg, M.A. Appl Microbiol Biotechnol (2011) 92: 45. doi:10.1007/s00253-011-3476-z


The genome sequence of Penicillium chrysogenum has initiated a range of fundamental studies, deciphering the genetic secrets of the industrial penicillin producer. More than 60 years of classical strain improvement has resulted in major but delicate rebalancing of the intracellular metabolism leading to the impressive penicillin titres of the current production strains. Several leads for further improvement are being followed up, including the use of P. chrysogenum as a cell factory for other products than β-lactam antibiotics.


Penicillium chrysogenum Genomics Antibiotics Metabolites Industrial production 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.DSM Biotechnology Center (699-0310)DelftThe Netherlands

Personalised recommendations